Vaginal Creams, Foams, and Jellies
"Vaginal Creams, Foams, and Jellies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.
| Descriptor ID |
D014622
|
| MeSH Number(s) |
D26.255.955 E07.357.750
|
| Concept/Terms |
Vaginal Tablet- Vaginal Tablet
- Tablet, Vaginal
- Tablets, Vaginal
- Vaginal Tablets
Vaginal Jelly- Vaginal Jelly
- Jellies, Vaginal
- Jelly, Vaginal
- Vaginal Jellies
- Vaginal Gel
- Gel, Vaginal
- Gels, Vaginal
- Vaginal Gels
Vaginal Creams- Vaginal Creams
- Cream, Vaginal
- Creams, Vaginal
- Vaginal Cream
Vaginal Foams- Vaginal Foams
- Foam, Vaginal
- Foams, Vaginal
- Vaginal Foam
|
Below are MeSH descriptors whose meaning is more general than "Vaginal Creams, Foams, and Jellies".
Below are MeSH descriptors whose meaning is more specific than "Vaginal Creams, Foams, and Jellies".
This graph shows the total number of publications written about "Vaginal Creams, Foams, and Jellies" by people in this website by year, and whether "Vaginal Creams, Foams, and Jellies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 1 | 1 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaginal Creams, Foams, and Jellies" by people in Profiles.
-
Social harms in female-initiated HIV prevention method research: state of the evidence. AIDS. 2019 11 15; 33(14):2237-2244.
-
Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention. AIDS Educ Prev. 2019 10; 31(5):433-451.
-
Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa. Eur J Contracept Reprod Health Care. 2019 Oct; 24(5):390-398.
-
End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
-
"It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis. AIDS Behav. 2018 Nov; 22(11):3692-3704.
-
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
-
The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa. AIDS Care. 2019 06; 31(6):660-666.
-
A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery. AIDS Behav. 2018 01; 22(1):127-132.
-
Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding". AIDS Behav. 2015 May; 19(5):784-93.
-
Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa. Soc Sci Med. 2014 Jun; 110:49-55.